case_images: PMC11816037_01
case_images: Physicians' responses regarding active surveillance (AS). (A) Physicians' responses about whether they would consider AS in each case. (B) Factors associated with physicians' decisions in case 1. (C) Factors associated with the physicians' decisions in case 2. Responses of 'definitely consider' and 'probably consider' were categorized as 'consider', while 'probably not consider' and 'definitely not consider' were categorized as 'not consider'. Logistic regression analysis was then performed, and an odds ratio > 1 indicates a higher likelihood of considering AS.
case_images: ETJ-24-0281fig1.jpg
case_images: PMC11816037_01_ETJ-24-0281fig1.jpg
case_images: fig1
case_images: In the first case, involving a 65-year-old man with a 0.7 cm thyroid cancer without extrathyroidal extension and LN metastasis, 74.6% of respondents indicated that they would consider AS (Fig. 1A). To identify the factors influencing the physicians' decisions, logistic regression analysis was conducted (Fig. 1B). AS (Fig. 1A). A logistic regression analysis to determine the factors associated with the physicians' decision in this second case was performed, but it yielded no significant results (Fig. 1C).
case_images: Physicians' perspectives on the potential benefits of active surveillance.
case_images: ETJ-24-0281fig2.jpg
case_images: PMC11816037_01_ETJ-24-0281fig2.jpg
case_images: fig2
case_images: AS (Fig. 2), respondents indicated that the primary advantages included avoiding surgery (49.8%) and reducing surgical complications (40.1%). Additionally, they noted an improved quality of life for patients (26.8%) as another significant benefit of AS.
case_images: Physicians' perspectives on the potential risks of active surveillance.
case_images: ETJ-24-0281fig3.jpg
case_images: PMC11816037_01_ETJ-24-0281fig3.jpg
case_images: fig3
case_images: When asked about the potential risks of AS (Fig. 3), physicians expressed significant concerns.
case_images: Challenges to screening appropriate patients for active surveillance.
case_images: ETJ-24-0281fig4.jpg
case_images: PMC11816037_01_ETJ-24-0281fig4.jpg
case_images: fig4
case_images: We identified factors that made it difficult to screen patients for AS (Fig. 4).
case_images: Unmet needs for active surveillance.
case_images: ETJ-24-0281fig5.jpg
case_images: PMC11816037_01_ETJ-24-0281fig5.jpg
case_images: fig5
case_images: AS for low-risk thyroid cancer patients (Fig. 5), the majority reported a need for psychological support to manage patient anxiety (88.9%) and reimbursement to reduce costs associated with long-term follow-up (88.5%). Additionally, 85.7% indicated a lack of information or educational materials on AS to share with patients, and 83.6% noted an insufficiency in cost-effectiveness data for AS.